Explore our drug discovery





Theranostic services









Theranostic development. One partner.

We support the full theranostic services workflow, from diagnostic imaging to therapeutic validation, giving innovators a single, integrated partner for radiopharmaceutical development.

Our platform delivers clean, quantitative data that accelerates pairing, optimisation and clinical translation. 


Dosimetry

























What we deliver 

  • Diagnostic–therapy pairing.
  • Radiochemistry for diagnostic and therapeutic isotopes.
  • Biodistribution, PK/PD and efficacy.
  • Imaging biomarkers (PET/SPECT).
  • Dosimetry and safety assessment.
  • IND/IMPD‑ready data packages.

One team. One workflow. One standard of quality.




Why work with us? 

  • In-house specialisms: Deep radiopharmaceutical biology expertise.
  • Full-stack in-house capability: Integrated radiochemistry, imaging and biology.
  • Regulatory‑ready: ISO 45001 certified, licensed for alpha & beta emitters and predictive human dosimetry from pre-clinical data.
  • Built for reliability: Access and multiple supply agreements across our library of isotopes.
  • Global credibility: Our environment is built for regulatory credibility – whether your next step is the FDA, EMA and MHRA.
  • Trusted by innovators: Regulatory‑ready outputs.

If you need a seamless theranostic partner, come and work with us.


























World-class minds for RPT discovery and development

In the complex landscape of radiochemistry and translational imaging, the difference lies in the expertise behind the science.

Our team comprises industry-leading specialists across preclinical services and radiopharmaceuticals, dedicated to bridging the gap between early discovery and clinical success.

Meet the experts who turn sophisticated data into actionable therapeutic insights.

Explore our scientific expertise

Case study: PSMA theranostic pairing

Brief: Pair diagnostic 89Zr tracer with 177Lu therapeutic.

We delivered: 

  • Radiolabelling for both isotopes.
  • PET biodistribution and therapeutic efficacy.
  • Dosimetry.

Outcome: Clear theranostic rationale and accelerated clinical planning.


























Start your project 

Ready to accelerate your theranostic development project? 

Our experts are here to support your journey from concept to clinic. Contact our team to discuss a tailored solution. 

Speak to the team, we’ll scope your project and get you moving fast. 




Expertise in radiolabelling

With gamma, beta and alpha-emitting radiometals of small molecules (e.g., FAPI, PSMA), peptides, proteins and other biologics containing chelators such as DOTA, DOTAM, Macropa, and DFO/DFO*. Experience in a variety of purification methods (e.g., ultrafiltration, SPE), QC analysis (HPLC, ITLC, gamma spectrometry), and conjugation techniques. 

Discover more






















Visualising impact in real-time

Utilising CDX and PDX models to deliver high-resolution longitudinal tumour growth inhibition (TGI) data and PK/PD analysis. 

Discover more






















Mapping the path to the target

Quantitative time-course activity analysis across 15+ organ systems using PET, SPECT and CT imaging, EBRT, US, Gamma counting and PK modelling. 

Discover more






















Ensuring safety and maximising therapeutic windows

Precise calculation of absorbed doses (Voxel/MIRD) to provide reliable preclinical-to-clinical dose extrapolation. 

Discover more






















The “See it, Treat it” advantage

Strategic pairing of diagnostic/therapeutic isotopes (e.g. 89Zr and 177Lu) to build companion imaging and patient-selection strategies. 

Discover more






















Early-stage de-risking

High-throughput screening for affinity, internalisation, and stability to identify lead candidates faster. 

Discover more






















Deep-dive tissue validation

Detailed cellular phenotyping through high-resolution autoradiography, gamma counting, and IHC correlation.

Discover more




























Explore more




We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult